Does GRASP affect DCE-MRI quantitative parameters and texture analysis in patients with esophageal cancer receiving preoperative neoadjuvant chemotherapy?

被引:1
|
作者
Lu, Yanan [1 ]
Ma, Ling [2 ]
Wang, Zhaoqi [1 ]
Guo, Jia [1 ]
Zhang, Hongkai [1 ]
Yan, Xu [3 ]
Liu, Hui [1 ]
Kamel, Ihab R. [5 ]
Li, Hailiang [1 ]
Qin, Jianjun [4 ]
Qu, Jinrong [1 ]
机构
[1] Zhengzhou Univ, Henan Canc Hosp, Affiliated Canc Hosp, Dept Radiol, Zhengzhou 450008, Henan, Peoples R China
[2] GE Healthcare, Adv Applicat Team, Shanghai 201203, Peoples R China
[3] Siemens Ltd China, NEA MR Collaborat, Shanghai 201318, Peoples R China
[4] Zhengzhou Univ, Henan Canc Hosp, Affiliated Canc Hosp, Dept Thorac Surg, Zhengzhou 450008, Henan, Peoples R China
[5] Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA
关键词
Magnetic resonance imaging; Esophageal cancer; Treatment outcome; Chemotherapy; Neoadjuvant therapy;
D O I
10.1007/s42058-019-00010-5
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose To compare pharmacokinetic parameters and texture features from two dynamic contrast-enhanced (DCE) MR images [golden-angle radial sparse parallel (GRASP) and view-sharing with golden-angle radial profile (VS-GR) reconstruction], and explore their value in assessing response to neoadjuvant chemotherapy (nCT) in esophageal cancer (EC). Methods The study prospectively enrolled 30 EC patients receiving nCT before surgery. DCE-MRI scanning was performed before nCT and within 1 week before surgery. Chemotherapy response was assessed according to RECIST 1.1 and Tumor Regression Grade (TRG). Mann-Whitney U test was utilized for comparing GRASP and VS-GR reconstruction, and the receiver operating characteristic (ROC) was performed for each significant feature to assess its accuracy in predicting response. Results Among the 30 patients included in this cohort (28 men; average age of 58 +/- 8 years), response by RECIST 1.1 demonstrated 18 responders and 12 non-responders. For TRG, no case showed TRG1, 1 patient was TRG2, 3 patients were TRG3, 8 patients were TRG4, and 18 patients were TRG5. A total of 72 pharmacokinetic parameters and texture features were extracted from each tumor. Of those, 29 pre-nCT features and 24 post-nCT features showed statistically significant difference between GRASP and VS-GR reconstruction. One pre-nCT texture feature and 37 post-nCT pharmacokinetic parameters and texture features on VS-GR showed statistically significant differences between responder and non-responders. Both pre- and post-nCT pharmacokinetic parameters and texture features with GRASP reconstruction showed good performance in response groups (AUC > 0.70, P < 0.05), and only post-nCT pharmacokinetic parameters and texture features with VS-GR reconstruction showed good performance in response groups (AUC > 0.70, P < 0.05). Conclusion GRASP can improve pharmacokinetic parameters and texture features from DCE-MR imaging. Both pre- and post-nCT pharmacokinetic parameters and texture features with GRASP and only post-nCT those with VS-GR reconstruction showed the ability to assess the response to nCT in EC.
引用
收藏
页码:25 / 33
页数:9
相关论文
共 50 条
  • [1] Does GRASP affect DCE-MRI quantitative parameters and texture analysis in patients with esophageal cancer receiving preoperative neoadjuvant chemotherapy?
    Yanan Lu
    Ling Ma
    Zhaoqi Wang
    Jia Guo
    Hongkai Zhang
    Xu Yan
    Hui Liu
    Ihab R. Kamel
    Hailiang Li
    Jianjun Qin
    Jinrong Qu
    [J]. Chinese Journal of Academic Radiology, 2019, 1 : 25 - 33
  • [2] The value of GRASP on DCE-MRI for assessing response to neoadjuvant chemotherapy in patients with esophageal cancer
    Lu, Yanan
    Ma, Ling
    Qin, Jianjun
    Wang, Zhaoqi
    Guo, Jia
    Zhao, Yan
    Zhang, Hongkai
    Yan, Xu
    Liu, Hui
    Li, Hailiang
    Kamel, Ihab R.
    Qu, Jinrong
    [J]. BMC CANCER, 2019, 19 (01)
  • [3] The value of GRASP on DCE-MRI for assessing response to neoadjuvant chemotherapy in patients with esophageal cancer
    Yanan Lu
    Ling Ma
    Jianjun Qin
    Zhaoqi Wang
    Jia Guo
    Yan Zhao
    Hongkai Zhang
    Xu Yan
    Hui Liu
    Hailiang Li
    Ihab R. Kamel
    Jinrong Qu
    [J]. BMC Cancer, 19
  • [4] Radiomic analysis of DCE-MRI for prediction of response to neoadjuvant chemotherapy in breast cancer patients
    Fan, Ming
    Wu, Guolin
    Cheng, Hu
    Zhang, Juan
    Shao, Guoliang
    Li, Lihua
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 2017, 94 : 140 - 147
  • [5] DCE-MRI radiomics nomogram can predict response to neoadjuvant chemotherapy in esophageal cancer
    Qu, Jinrong
    Ma, Ling
    Lu, Yanan
    Wang, Zhaoqi
    Guo, Jia
    Zhang, Hongkai
    Yan, Xu
    Liu, Hui
    Kamel, Ihab R.
    Qin, Jianjun
    Li, Hailiang
    [J]. DISCOVER ONCOLOGY, 2022, 13 (01)
  • [6] DCE-MRI radiomics nomogram can predict response to neoadjuvant chemotherapy in esophageal cancer
    Jinrong Qu
    Ling Ma
    Yanan Lu
    Zhaoqi Wang
    Jia Guo
    Hongkai Zhang
    Xu Yan
    Hui Liu
    Ihab R. Kamel
    Jianjun Qin
    Hailiang Li
    [J]. Discover Oncology, 13
  • [7] Habitat Analysis of DCE-MRI Predicts for Response to Neoadjuvant Chemotherapy in Breast Cancer
    Silver, Benjamin
    Obeid, Jean-Pierre
    Chan, Yu-Cherng C.
    Takita, Cristiane
    Stoyanova, Radka
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 101 (02): : E12 - E13
  • [8] Predictive value of neoadjuvant chemotherapy on breast cancer subtypes evaluated by DCE-MRI and MRI perfusion parameters
    Han, Bing
    Pan, Shushu
    Ruan, Mei
    [J]. INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY, 2023, 61 (10) : 807 - 812
  • [9] Quantitative DCE-MRI prediction of breast cancer recurrence following neoadjuvant chemotherapy: a preliminary study
    Thawani, Rajat
    Gao, Lina
    Mohinani, Ajay
    Tudorica, Alina
    Li, Xin
    Mitri, Zahi
    Huang, Wei
    [J]. BMC MEDICAL IMAGING, 2022, 22 (01)
  • [10] Quantitative DCE-MRI prediction of breast cancer recurrence following neoadjuvant chemotherapy: a preliminary study
    Rajat Thawani
    Lina Gao
    Ajay Mohinani
    Alina Tudorica
    Xin Li
    Zahi Mitri
    Wei Huang
    [J]. BMC Medical Imaging, 22